It was found that direct intracerebral administration of LBNSE-GM-CSF could induce innate and adaptive immune responses, allowing immune effectors enter into the CNS to clear the virus and prevent the development of rabies as late as 5 days after infection. The gene discussed is CSF2; the disease is infection.